1. Home
  2. STVN vs BIRK Comparison

STVN vs BIRK Comparison

Compare STVN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • BIRK
  • Stock Information
  • Founded
  • STVN 1949
  • BIRK 1774
  • Country
  • STVN Italy
  • BIRK United Kingdom
  • Employees
  • STVN N/A
  • BIRK N/A
  • Industry
  • STVN Containers/Packaging
  • BIRK
  • Sector
  • STVN Consumer Discretionary
  • BIRK
  • Exchange
  • STVN Nasdaq
  • BIRK Nasdaq
  • Market Cap
  • STVN 7.4B
  • BIRK 8.8B
  • IPO Year
  • STVN 2021
  • BIRK 2023
  • Fundamental
  • Price
  • STVN $25.98
  • BIRK $41.99
  • Analyst Decision
  • STVN Buy
  • BIRK Strong Buy
  • Analyst Count
  • STVN 4
  • BIRK 11
  • Target Price
  • STVN $25.13
  • BIRK $68.82
  • AVG Volume (30 Days)
  • STVN 304.7K
  • BIRK 2.2M
  • Earning Date
  • STVN 11-06-2025
  • BIRK 12-17-2025
  • Dividend Yield
  • STVN 0.24%
  • BIRK N/A
  • EPS Growth
  • STVN 6.78
  • BIRK 178.47
  • EPS
  • STVN 0.57
  • BIRK 1.92
  • Revenue
  • STVN $1,344,798,591.00
  • BIRK $2,380,334,704.00
  • Revenue This Year
  • STVN $8.33
  • BIRK $18.25
  • Revenue Next Year
  • STVN $10.12
  • BIRK $14.29
  • P/E Ratio
  • STVN $45.22
  • BIRK $22.06
  • Revenue Growth
  • STVN 5.28
  • BIRK 17.60
  • 52 Week Low
  • STVN $17.23
  • BIRK $40.56
  • 52 Week High
  • STVN $28.00
  • BIRK $62.66
  • Technical
  • Relative Strength Index (RSI)
  • STVN 53.46
  • BIRK 35.42
  • Support Level
  • STVN $25.43
  • BIRK $41.00
  • Resistance Level
  • STVN $27.99
  • BIRK $43.39
  • Average True Range (ATR)
  • STVN 1.23
  • BIRK 1.06
  • MACD
  • STVN 0.22
  • BIRK 0.14
  • Stochastic Oscillator
  • STVN 59.64
  • BIRK 29.77

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

Share on Social Networks: